PROCEPT BIOROBOTICS CORP (PRCT) — insider trading
Health Care · NASDAQ
PROCEPT BIOROBOTICS CORP (PRCT) has 33 reported SEC Form 4 insider transactions in our data, including 1 open-market purchase and 6 open-market sales among the most recent 33 (latest 2026-10-02).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Mack Michael | Director | Grant / award / vesting (derivative) | 12,191 | — | $0 | Form 4 |
| 2026-10-02 | Mack Michael | Director | Grant / award / vesting | 7,727 | — | $0 | Form 4 |
| 2026-09-09 | Waters Kevin | Officer (EVP, CFO) | Open-market sale | 373 | $20.95 | $7.8K | Form 4 |
| 2026-09-09 | Templin Barry L | Officer (EVP, Chief Technology Officer) | Open-market sale | 373 | $20.95 | $7.8K | Form 4 |
| 2026-09-09 | Nouri Alaleh | Officer (EVP, CLO, CORP. SEC.) | Open-market sale | 297 | $20.95 | $6.2K | Form 4 |
| 2026-08-13 | Sharma Pooja | Officer (Chief Strat/Marketing Officer) | Grant / award / vesting (derivative) | 32,681 | — | $0 | Form 4 |
| 2026-08-13 | Sharma Pooja | Officer (Chief Strat/Marketing Officer) | Grant / award / vesting | 23,622 | — | $0 | Form 4 |
| 2026-08-13 | Waters Kevin | Officer (EVP, CFO) | Grant / award / vesting (derivative) | 40,851 | — | $0 | Form 4 |
| 2026-08-13 | Waters Kevin | Officer (EVP, CFO) | Grant / award / vesting | 29,527 | — | $0 | Form 4 |
| 2026-08-13 | Templin Barry L | Officer (EVP, Chief Technology Officer) | Grant / award / vesting (derivative) | 36,312 | — | $0 | Form 4 |
| 2026-08-13 | Templin Barry L | Officer (EVP, Chief Technology Officer) | Grant / award / vesting | 26,246 | — | $0 | Form 4 |
| 2026-08-13 | Nouri Alaleh | Officer (EVP, CLO, CORP. SEC.) | Grant / award / vesting (derivative) | 31,773 | — | $0 | Form 4 |
| 2026-08-13 | Nouri Alaleh | Officer (EVP, CLO, CORP. SEC.) | Grant / award / vesting | 22,965 | — | $0 | Form 4 |
| 2026-08-07 | Wood Larry L | Director, Officer (President, CEO) | Open-market purchase | 23,900 | $20.85 | $498.3K | Form 4 |
| 2026-06-09 | PUCKETT DAN | Director | Grant / award / vesting (derivative) | 5,853 | — | $0 | Form 4 |
| 2026-06-09 | PUCKETT DAN | Director | Grant / award / vesting | 3,315 | — | $0 | Form 4 |
| 2026-06-09 | PRESCOTT THOMAS M | Director | Grant / award / vesting (derivative) | 5,853 | — | $0 | Form 4 |
| 2026-06-09 | PRESCOTT THOMAS M | Director | Grant / award / vesting | 3,315 | — | $0 | Form 4 |
| 2026-06-09 | MOLL FREDERIC H | Director | Grant / award / vesting (derivative) | 5,853 | — | $0 | Form 4 |
| 2026-06-09 | MOLL FREDERIC H | Director | Grant / award / vesting | 3,315 | — | $0 | Form 4 |
| 2026-06-09 | Little Elisabeth Sandoval | Director | Grant / award / vesting (derivative) | 5,853 | — | $0 | Form 4 |
| 2026-06-09 | Little Elisabeth Sandoval | Director | Grant / award / vesting | 3,315 | — | $0 | Form 4 |
| 2026-06-09 | Harris Taylor C. | Director | Grant / award / vesting (derivative) | 5,853 | — | $0 | Form 4 |
| 2026-06-09 | Harris Taylor C. | Director | Grant / award / vesting | 3,315 | — | $0 | Form 4 |
| 2026-06-09 | Garrett Mary | Director | Grant / award / vesting (derivative) | 5,853 | — | $0 | Form 4 |
| 2026-06-09 | Garrett Mary | Director | Grant / award / vesting | 3,315 | — | $0 | Form 4 |
| 2026-06-09 | Dodrill Amy M. | Director | Grant / award / vesting (derivative) | 5,853 | — | $0 | Form 4 |
| 2026-06-09 | Dodrill Amy M. | Director | Grant / award / vesting | 3,315 | — | $0 | Form 4 |
| 2026-06-09 | Desai Antal Rohit | Director | Grant / award / vesting (derivative) | 5,853 | — | $0 | Form 4 |
| 2026-06-09 | Desai Antal Rohit | Director | Grant / award / vesting | 3,315 | — | $0 | Form 4 |
| 2026-06-08 | Templin Barry L | Officer (EVP, Chief Technology Officer) | Open-market sale | 358 | $28.48 | $10.2K | Form 4 |
| 2026-06-08 | Waters Kevin | Officer (EVP, CFO) | Open-market sale | 357 | $28.48 | $10.2K | Form 4 |
| 2026-06-08 | Nouri Alaleh | Officer (EVP, CLO, CORP. SEC.) | Open-market sale | 285 | $28.48 | $8.1K | Form 4 |
Ask the chat about PRCT's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: PROCEPT BIOROBOTICS CORP (PRCT).
Last updated 2026-10-02 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.